Skip to content

Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography

Validation of Breathing Event Detection of the Philips Respironics Sleep Therapy System REMstar Auto A-Flex Compared to Clinical Polysomnography

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01175031
Enrollment
45
Registered
2010-08-04
Start date
2010-09-30
Completion date
2013-09-30
Last updated
2018-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cheyne-Stokes Respiration, Obstructive Sleep Apnea, Sleep Apnea Central

Brief summary

The purpose of this study is to demonstrate diagnostic agreement and determine the accuracy of the continuous positive airway pressure (CPAP) device compared to simultaneous, attended clinical polysomnography (PSG) in identifying breathing events in participants previously diagnosed with complex sleep apnea (CompSAS), complex sleep apnea with Cheyne-Stokes respiration (CSR), or obstructive sleep apnea (OSA).

Detailed description

Study Objectives: To compare a positive airway pressure (PAP) device's detection of respiratory events and airway status during device detected apneas with events scored on simultaneous polysomnography (PSG). Design: Prospective PSGs of patients with sleep apnea using a new-generation PAP device. Settings: Four clinical and academic sleep centers. Patients: Forty-five patients with obstructive sleep apnea (OSA) and complex sleep apnea (Comp SA) performed a PSG on PAP levels adjusted to induce respiratory events. Interventions: None.

Interventions

OTHERManipulation of Positive Airway Pressure (PAP)

Positive airway pressure (PAP) will be manipulated throughout the night to induce breathing events. PAP will be set to the participant's prescribed pressure, increased until breathing events are induced , and then returned to the prescribed pressure. This cyclic pattern will continue throughout the night.

Sponsors

Philips Respironics
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Males and females, ages 21-80. * Able and willing to provide written informed consent. * Diagnosis of complex sleep apnea (CompSAS) or Obstructive Sleep Apnea (OSA) within one year of study participation. * For participants with CompSAS: (a) Diagnostic PSG with an Apnea-Hyopnea Index (AHI) greater than or equal to 10 events/hour and central apnea index (CAI) greater than or equal to 5 events/hour of sleep or (b) PAP titration with a CAI greater than or equal to 5 events/hour of sleep. * For participants with OSA, a diagnostic PSG with an AHI greater than or equal to 15 events/hour of sleep. * Must have had a CPAP titration such that the necessary PAP level to treat the sleep disordered breathing is known. * Agreement to undergo a full-night, in-laboratory PSG on CPAP device.

Exclusion criteria

* Participation in an interventional research study within 30 days of study participation. * Pre-menopausal females known to be pregnant or who are sexually active and not using a reliable method of birth control. * Surgery of the upper airway, nose, sinus, or middle ear within the last 90 days. * Surgery at any time for the treatment of OSA such as uvulopalatopharyngoplasty (UPPP). * Major medical or psychiatric condition that would interfere with the demands of the study, adherence to positive airway pressure, or the ability to complete the study. * Chronic respiratory failure or insufficiency with suspected or known neuromuscular disease, moderate or severe Chronic Obstructive Pulmonary Disease (COPD) or other pulmonary disorders, or any condition with an elevation of arterial carbon dioxide levels (\> 45 mmHg) while awake. * Currently prescribed oxygen therapy. * Ventilatory induced barotrauma within 6 months of study participation. * Untreated insomnia. * Other major medical condition that, in the judgment of the investigator, precludes participation in this study.

Design outcomes

Primary

MeasureTime frameDescription
Number of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous PolysomnographyDuring a single night of polysomnography lasting an average of 8 hoursThe following breathing events: RERAs, central apneas, periodic breathing, obstructive apneas, and hypopneas in patients previously diagnosed with CompSAS or OSA detected by simultaneous Polysomnography and REMstar Auto with A-Flex were compared.

Secondary

MeasureTime frameDescription
Device Detected Apneas as Detected by Philips Respironics (PR) System OneDuring a single night of polysomnography lasting an average of 8 hoursAll device-detected apneas were tabulated. Then they were broken down into obstructed airway apneas and clear airway apneas. The results are recorded below as apneas with obstructed airway and apneas with clear airway.
Device-Detected Obstructed Airway Apnea AgreementDuring a single night of polysomnography lasting an average of 8 hoursDevice-Detected Apneas were broken down and then reviewed with the manually scored apneas. Of the Obstructed Airway apneas they were broken down into a few different categories: Manually Scored Obstructive Apneas, Manually Scored Central Apneas, Manually Scored Hypopneas and Manually Scored RERAs.
Device-Detected Clear Airway Apnea AgreementDuring a single night of polysomnography lasting an average of 8 hoursDevice Detected Clear Airways events were counted by the device. These events were then compared to manual PSG scoring. The manual PSG scoring determined that these were apnea events. However, the manual scoring allows for more channels to be reviewed and manual scoring was able to classify them into 4 different categories: Manually Scored Obstructive Apneas, Manually Scored Central Apneas, Manually scored hypopneas and manually scored RERAs.

Countries

United States

Participant flow

Participants by arm

ArmCount
Sleep Apnea
Individuals with Obstructive Sleep Apnea (OSA); Complex Sleep Apnea (CompSAS) and central apnea index (CAI), or the PSG during PAP treatment had a central apnea index ≥ 5 events/h after obstructive apneas resolved.
45
Total45

Baseline characteristics

CharacteristicSleep Apnea
Age, Continuous53.2 years
STANDARD_DEVIATION 13.9
Body mass index53.2 kg/m^2
STANDARD_DEVIATION 13.9
Diagnosis
Complex Sleep Apnea
13 participants
Diagnosis
Obstructive Sleep apnea
32 participants
Diagnostic Apnea-Hypopnea Index (AHI)39.3 events/hour
STANDARD_DEVIATION 26
Race/Ethnicity, Customized
African American
8 participants
Race/Ethnicity, Customized
Caucasian
32 participants
Race/Ethnicity, Customized
Hispanic/Latino
2 participants
Race/Ethnicity, Customized
Others
3 participants
Region of Enrollment
United States
45 participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
29 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 45
serious
Total, serious adverse events
0 / 45

Outcome results

Primary

Number of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous Polysomnography

The following breathing events: RERAs, central apneas, periodic breathing, obstructive apneas, and hypopneas in patients previously diagnosed with CompSAS or OSA detected by simultaneous Polysomnography and REMstar Auto with A-Flex were compared.

Time frame: During a single night of polysomnography lasting an average of 8 hours

ArmMeasureGroupValue (MEAN)Dispersion
REMstar Auto With A-FlexNumber of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous PolysomnographyApnea-hyopnea index16.5 events/hourStandard Deviation 13.5
REMstar Auto With A-FlexNumber of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous PolysomnographyApnea index11.4 events/hourStandard Deviation 9.9
REMstar Auto With A-FlexNumber of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous PolysomnographyHypopnea index5.1 events/hourStandard Deviation 5
REMstar Auto With A-FlexNumber of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous PolysomnographyRespiratory effort-related arousal (RERA) index2.8 events/hourStandard Deviation 2
Manually Scored Polysomnography (PSG)Number of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous PolysomnographyRespiratory effort-related arousal (RERA) index6.3 events/hourStandard Deviation 7.4
Manually Scored Polysomnography (PSG)Number of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous PolysomnographyApnea-hyopnea index18.1 events/hourStandard Deviation 18.6
Manually Scored Polysomnography (PSG)Number of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous PolysomnographyHypopnea index6.6 events/hourStandard Deviation 7.5
Manually Scored Polysomnography (PSG)Number of Breathing Events Identified by the Continuous Positive Airway Pressure (CPAP) Device Compared to a Simultaneous PolysomnographyApnea index11.5 events/hourStandard Deviation 16
p-value: 0.003signed-rank tests
Secondary

Device Detected Apneas as Detected by Philips Respironics (PR) System One

All device-detected apneas were tabulated. Then they were broken down into obstructed airway apneas and clear airway apneas. The results are recorded below as apneas with obstructed airway and apneas with clear airway.

Time frame: During a single night of polysomnography lasting an average of 8 hours

Population: 1097 Device Detected Apneas were detected.

ArmMeasureGroupValue (NUMBER)
REMstar Auto With A-FlexDevice Detected Apneas as Detected by Philips Respironics (PR) System OneApnea with obstructed Airway762 events
REMstar Auto With A-FlexDevice Detected Apneas as Detected by Philips Respironics (PR) System OneApnea with clear airway335 events
Secondary

Device-Detected Clear Airway Apnea Agreement

Device Detected Clear Airways events were counted by the device. These events were then compared to manual PSG scoring. The manual PSG scoring determined that these were apnea events. However, the manual scoring allows for more channels to be reviewed and manual scoring was able to classify them into 4 different categories: Manually Scored Obstructive Apneas, Manually Scored Central Apneas, Manually scored hypopneas and manually scored RERAs.

Time frame: During a single night of polysomnography lasting an average of 8 hours

Population: 335 Device Detected Clear Airway Apneas were detected.

ArmMeasureGroupValue (NUMBER)
REMstar Auto With A-FlexDevice-Detected Clear Airway Apnea AgreementManually Scored Obstructive Apnea53 events
REMstar Auto With A-FlexDevice-Detected Clear Airway Apnea AgreementManually Scored Central Apnea209 events
REMstar Auto With A-FlexDevice-Detected Clear Airway Apnea AgreementManually Scored Hypopnea49 events
REMstar Auto With A-FlexDevice-Detected Clear Airway Apnea AgreementManually Scored RERA24 events
Secondary

Device-Detected Obstructed Airway Apnea Agreement

Device-Detected Apneas were broken down and then reviewed with the manually scored apneas. Of the Obstructed Airway apneas they were broken down into a few different categories: Manually Scored Obstructive Apneas, Manually Scored Central Apneas, Manually Scored Hypopneas and Manually Scored RERAs.

Time frame: During a single night of polysomnography lasting an average of 8 hours

Population: 762 Device Detected Apneas were detected.

ArmMeasureGroupValue (NUMBER)
REMstar Auto With A-FlexDevice-Detected Obstructed Airway Apnea AgreementManually Scored Obstructive Apnea367 events
REMstar Auto With A-FlexDevice-Detected Obstructed Airway Apnea AgreementManually Scored Central Apnea159 events
REMstar Auto With A-FlexDevice-Detected Obstructed Airway Apnea AgreementManually Scored Hypopnea180 events
REMstar Auto With A-FlexDevice-Detected Obstructed Airway Apnea AgreementManually Scored RERA56 events

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026